do not combine dpp-4 inhibitors with glp-1 receptor agonists recommendation It's the first in a class of drugs called Insights into the Roles of
Description
Patients with a history of pancreatitis were excluded from trials, so it is unknown if they are at greater risk

Short term monotherapy with exenatide is superior to Metformin in weight loss, improving insulin resistance and inflammation in Chinese overweight/obese PCOS women

In conclusion, the role of GLP-1RAs in the management of DR remains a nuanced and evolving topic
We however think that GLP-1RAs should be avoided in people with HF with reduced ejection fraction until robust evidence of benefit is generated in this group